Binding and modulation of p53 by p300/CBP coactivators

Nature

Volumn 387, Issue 6635, 1997, Pages 823-827

  Lill, Nancy L ^a,b   Grossman, Steven R ^a   Ginsberg, Doron ^a,c   DeCaprio, James ^a   Livingston, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CELL CYCLE; CELL TRANSFORMATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION;

3T3 CELLS; ADENOVIRUS E1A PROTEINS; ANIMALS; APOPTOSIS; CELL CYCLE; CELL LINE; CELL NUCLEUS; CREB-BINDING PROTEIN; DNA; E1A-ASSOCIATED P300 PROTEIN; G1 PHASE; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0030973238     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/42981     Document Type: Article

References (30)

1. Lill, N. L. et al. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71, 129-137 (1997).
2. Eckner, R. et al. Associatin of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16, 3454-3464 (1996).
3. Chowdary, D. R. et al. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14, 1997-2003 (1994).
4. Steengenga, W. T. et al. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol. 16, 2101-2109 (1996).
5. Eckner, R. et al. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8, 869-884 (1994).
6. Kern, S. E. et al. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256, 827-830 (1992).
7. Stein, R. W. et al. Analysis of E1A mediated growth regulation functions binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. J. Virol. 64, 4421-4427 (1990).
8. Howe, J. A. & Bayley, S. T. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastomas protein and cyclin A. Virology 186, 15-24 (1992).
9. El-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
10. Miyashita, T. & Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
11. Yang, X. J. et al. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382, 319-324 (1996).
12. Eckner, R. et al. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10, 2478-2490 (1996).
13. Yao, T.-P. et al. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc. Natl Acad. Sci. USA 93, 10626-10631 (1996).
14. Diller, L. et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10, 5772-5781 (1990).
15. Haupt, Y. et al. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170-2183 (1990).
16. Chen, X. et al. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-2451 (1996).
17. Bayley, S. T. & Mymryk, J. S. Adenovirus E1A proteins and transformation. Int. J. Oncol. 5, 425-444 (1994).
18. Caporossi, D. & Bacchetti, S. Definition of the adenovirus type 5 functions involved in the induction of chromosomal aberrations in human cells. J. Gen. Virol. 71, 801-808 (1990).
19. Abraham, S. E. et al. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8, 1639-1647 (1993).
20. Ko, L. J. & Prives, C. p53: puzzle and paradigm. Genes Dev. 10, 1054-1072 (1996).
21. Baker, S. J. et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249, 912-915 (1990).
22. White, E. et al. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65, 2968-2978 (1991).
23. Kahana, J. & Silver, P. in Current Protocols in Molecular Biology (eds Ausubel, F. M. et al.) 9.7.22-9.7.28 (Greene and Wiley Interscience, New York, 1996).
24. Zhu, L. et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma proteins. Genes Dev. 7, 1111-1125 (1993).
25. Ausubel, F. M. et al. Current Protocols in Molecular Biology (Greene and Wiley Interscience, New York, 1996).
26. Krek, W., Livingston, D. M. & Shirodkar, S. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family member. Science 262, 1557-1560 (1993).
27. Chittenden, T., Livingston, D. M. & DeCaprio, J. A. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F. Mol. Cell. Biol. 13, 3975-3983 (1993).
28. Friedlander, P et al. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16, 4961-4971 (1996).
29. Qin, X.-Q. et al. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15, 742-755, (1995).
30. Somasundaram, K. & El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14, 1047-1057 (1997).